Patrick Pace, M.D.Managing Director at UTIMCO
As a Managing Director on UTIMCO’s Private Equity team, Pat oversees all investments in Private Equity, Venture Capital, and Private Credit globally. He also sits on UTIMCO’s Leadership Team and Investment Committee. Pat joined UTIMCO after working with EDG Partners as an Advisor. Previously, he served as Managing Director at Citadel Investment Group. Prior to Citadel, Pat led healthcare high yield and distressed debt investing as part of AIG Investments, served as a Senior Analyst covering the medical device industry at UBS, and worked in Equities at Credit Suisse First Boston. Dr. Pace began his career as a resident in Otolaryngology (ENT) at the University of Virginia Hospital.
Pat serves on the board of Encision (ECIA) and as Chairman of Nanospectra Biosciences. He participates on the Advisory Council for the UT-Health School of Biomedical Informatics and on the Investment Committee for the St. David’s Foundation.
Pat received a Bachelor of Arts, with Honors in Psychology, from Vanderbilt University and a Doctor of Medicine from The University of Texas Medical School at Houston.